Illumina Inc (ILMN)

ILMN (NASDAQ:Drugs) EQUITY
$184.86
pos +0.00
+0.00%
Today's Range: 182.95 - 185.95 | ILMN Avg Daily Volume: 984,900
Last Update: 04/28/17 - 4:00 PM EDT
Volume: 0
YTD Performance: 44.38%
Open: $0.00
Previous Close: $183.74
52 Week Range: $119.37 - $186.88
Oustanding Shares: 146,004,304
Market Cap: 26,826,830,817
6-Month Chart
TheStreet Ratings Grade for ILMN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 9 7 6
Moderate Buy 1 1 1 1
Hold 5 5 7 7
Moderate Sell 0 0 0 0
Strong Sell 3 3 3 3
Mean Rec. 2.24 2.24 2.46 2.55
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 59.85
Price Earnings Comparisons:
ILMN Sector Avg. S&P 500
59.85 36.70 29.50
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
14.83% 36.18% 38.21%
GROWTH 12 Mo 3 Yr CAGR
Revenue 8.00 0.70 0.19
Net Income -6.40 2.40 0.50
EPS -1.00 2.10 0.45
Earnings for ILMN:
EBITDA 0.75B
Revenue 2.40B
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (12/17) FY (12/18)
Average Estimate $0.69 $1.07 $3.64 $4.36
Number of Analysts 10 11 13 13
High Estimate $0.72 $1.15 $3.70 $4.66
Low Estimate $0.65 $0.99 $3.57 $4.01
Prior Year $0.86 $0.97 $3.33 $3.64
Growth Rate (Year over Year) -20.12% 9.93% 9.40% 19.78%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Charts show ILMN is close to offering a great profit opportunity.

Novice Trade: Illumina Real Money Pro($)

ILMN's three-month at-the-money implied volatility is at about the median level.
With very low oversold readings and a possible reversal pattern, we would at least cover shorts, and would consider probing the long side.
The five-day market win streak stalled a bit today. Though the close was weak, I still give the win to the bulls because of the modest drop in the averages after an 80-handle rise in the S&P index. That said, there was less than meets the eye as, taking out the share price gains of DuPont (DD) and Chevron (CVX), the market would have produced a less-stellar day. A lot of dead-cat bounces, me thinks! Remember Bob Farrell's lesson -- that when the laggards lead, it's typically a worrisome signpost. Energy and biotech caught bids and might be ripe for a near-term rally, albeit from low levels. Banks unchanged. Bonds closed at the day's highs; municipals and our closed-end muni funds were well-bid. Junk was up for a change! Crude was better. The U.S. dollar was a tad weaker. A technician's field day - Doji, evening stars and three peaks and a domed house!  I will be interested if the bullish investor sentiment rises a lot in this week's surveys; I suspect so! We are setting up for an interesting earnings season, even more than usual considering the crosswinds and headwinds.  If big misses at Yum! Brands (YUM), Adobe Systems (ADBE), Illumina (ILMN) and DuPont foreshadow a very weak third-quarter earnings season (and poor forward guidance), you want to be "all in" short, in my view. I sold Oaktree Capi
This move in health care takes your breath away.
Take advantage of elevated option premiums to gain long exposure to biotech.
With such a commanding lead in the sequencing business the stock can't stay down for long.
Bearish
Oct 06, 2015 | 7:15 AM EDT
Shares of ILMN now seen reaching $155, according to Leerink Partners. Estimates also cut, given the company's new guidance. Market Perf...
Bearish
Oct 01, 2015 | 7:15 AM EDT
ILMN was downgraded from Outperform to Market Perform, Leerink Partners said. $185 price target. Company lacks near-term catalysts.&nbs...
Bullish
Aug 26, 2015 | 7:14 AM EDT
ILMN was placed on the Focus List, Citigroup said. Shares have pulled back 13% month-to-date. $240 price target. 

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.